Protocol for using Multiomics2Targets to identify targets and driver kinases for cancer cohorts profiled with

Giacomo B Marino1, Eden Z Deng1, Daniel J B Clarke1

  • 1Department of Pharmacological Sciences, Mount Sinai Center for Bioinformatics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1603, New York, NY 10029, USA.

STAR Protocols
|November 20, 2024
PubMed

Insights

This study introduces Multiomics2Targets, a computational pipeline for analyzing multi-omics cancer data. It identifies key cancer targets, including cell signaling pathways and protein kinases, for potential immunotherapy treatments.

Area of Science:

  • Computational biology
  • Cancer research
  • Immunotherapy

Background:

  • Multi-omics data for cancer profiling is increasingly available.
  • Identifying actionable targets from complex datasets remains a challenge.

Purpose of the Study:

  • To present a computational pipeline, Multiomics2Targets, for analyzing multi-omics cancer data.
  • To enable the identification of driver cell signaling pathways, protein kinases, and cell-surface targets for immunotherapy.

Main Methods:

  • The protocol details data preparation and file uploading.
  • It includes steps for parameter tuning and workflow execution.
  • Visualization, export, and sharing of analysis reports are described.

Main Results:

  • The pipeline facilitates the identification of critical molecular targets within cancer cohorts.
  • It provides a structured approach to translating multi-omics data into potential therapeutic strategies.

Conclusions:

  • Multiomics2Targets offers a standardized protocol for leveraging multi-omics data in cancer research.
  • The pipeline aids in discovering novel targets for developing effective cancer immunotherapies.